Literature DB >> 22976053

Identification of a novel bone morphogenetic protein (BMP)-inducible transcript, BMP-inducible transcript-1, by utilizing the conserved BMP-responsive elements in the Id genes.

Masashi Shin1, Satoshi Ohte, Toru Fukuda, Hiroki Sasanuma, Katsumi Yoneyama, Shoichiro Kokabu, Arei Miyamoto, Sho Tsukamoto, Hirohiko Hohjoh, Eijiro Jimi, Takenobu Katagiri.   

Abstract

Bone morphogenetic proteins (BMPs) inhibit myogenesis and induce osteoblastic differentiation in myoblasts. They also induce the transcription of several common genes, such as Id1, Id2 and Id3, in various cell types. We have reported that a GC-rich element in the Id1 gene functions as a BMP-responsive element (BRE) that is regulated by Smads. In this study, we analyzed and identified BREs in the 5'-flanking regions of the mouse Id2 and Id3 genes. The core GGCGCC sequence was conserved among the BREs in the Id1, Id2 and Id3 genes and was essential for the response to BMP signaling via Smads. We found a novel BRE on mouse chromosome 13 at position 47,723,740-47,723,768 by searching for conserved sequences containing the Id1 BRE. This potential BRE was found in the 5'-flanking region of a novel gene that produces a non-coding transcript, termed BMP-inducible transcript-1 (BIT-1), and this element regulated the expression of this gene in response to BMP signaling. We found that BIT-1 is expressed in BMP target tissues such as the testis, brain, kidney and cartilage. These findings suggest that the transcriptional induction of the Ids, BIT-1 and additional novel genes containing the conserved BRE sequence may play an important role in the regulation of the differentiation and/or function of target cells in response to BMPs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22976053     DOI: 10.1007/s00774-012-0381-1

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  21 in total

1.  Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter.

Authors:  W Ishida; T Hamamoto; K Kusanagi; K Yagi; M Kawabata; K Takehara; T K Sampath; M Kato; K Miyazono
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

Review 2.  Signal transduction by the TGF-beta superfamily.

Authors:  Liliana Attisano; Jeffrey L Wrana
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

3.  Transcriptional regulation of BMP4 synexpression in transgenic Xenopus.

Authors:  Emil Karaulanov; Walter Knöchel; Christof Niehrs
Journal:  EMBO J       Date:  2004-02-12       Impact factor: 11.598

4.  Identification of BMP-responsive elements in the mouse Id2 gene.

Authors:  Takeshi Nakahiro; Hisanori Kurooka; Kentaro Mori; Kazuo Sano; Yoshifumi Yokota
Journal:  Biochem Biophys Res Commun       Date:  2010-07-30       Impact factor: 3.575

5.  Bone: formation by autoinduction.

Authors:  M R Urist
Journal:  Science       Date:  1965-11-12       Impact factor: 47.728

6.  Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis.

Authors:  Takenobu Katagiri; Mana Imada; Takeshi Yanai; Tatsuo Suda; Naoyuki Takahashi; Ryutaro Kamijo
Journal:  Genes Cells       Date:  2002-09       Impact factor: 1.891

7.  The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.

Authors:  Masashi Shin; Kou Matsuo; Takeyuki Tada; Hidefumi Fukushima; Hiroyuki Furuta; Satoru Ozeki; Tomoko Kadowaki; Kenji Yamamoto; Masato Okamoto; Eijiro Jimi
Journal:  Carcinogenesis       Date:  2011-09-01       Impact factor: 4.944

8.  A systems approach reveals that the myogenesis genome network is regulated by the transcriptional repressor RP58.

Authors:  Shigetoshi Yokoyama; Yoshiaki Ito; Hiroe Ueno-Kudoh; Hirohito Shimizu; Kenta Uchibe; Sonia Albini; Kazuhiko Mitsuoka; Shigeru Miyaki; Minako Kiso; Akane Nagai; Tomohiro Hikata; Tadahiro Osada; Noritsugu Fukuda; Satoshi Yamashita; Daisuke Harada; Valeria Mezzano; Masataka Kasai; Pier Lorenzo Puri; Yoshihide Hayashizaki; Haruo Okado; Megumi Hashimoto; Hiroshi Asahara
Journal:  Dev Cell       Date:  2009-12       Impact factor: 12.270

9.  Bone morphogenetic protein-2 does not alter the differentiation pathway of committed progenitors of osteoblasts and chondroblasts.

Authors:  M Komaki; T Katagiri; T Suda
Journal:  Cell Tissue Res       Date:  1996-04       Impact factor: 5.249

10.  ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif.

Authors:  Masato Morikawa; Daizo Koinuma; Shuichi Tsutsumi; Eleftheria Vasilaki; Yasuharu Kanki; Carl-Henrik Heldin; Hiroyuki Aburatani; Kohei Miyazono
Journal:  Nucleic Acids Res       Date:  2011-07-15       Impact factor: 16.971

View more
  8 in total

Review 1.  Bone Morphogenetic Proteins.

Authors:  Takenobu Katagiri; Tetsuro Watabe
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

2.  Mutant activin-like kinase 2 in fibrodysplasia ossificans progressiva are activated via T203 by BMP type II receptors.

Authors:  Mai Fujimoto; Satoshi Ohte; Kenji Osawa; Arei Miyamoto; Sho Tsukamoto; Takato Mizuta; Shoichiro Kokabu; Naoto Suda; Takenobu Katagiri
Journal:  Mol Endocrinol       Date:  2015-01

3.  Synergistic interaction between the fibroblast growth factor and bone morphogenetic protein signaling pathways in lens cells.

Authors:  Bruce A Boswell; Linda S Musil
Journal:  Mol Biol Cell       Date:  2015-05-06       Impact factor: 4.138

4.  Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling.

Authors:  S Tsukamoto; T Mizuta; M Fujimoto; S Ohte; K Osawa; A Miyamoto; K Yoneyama; E Murata; A Machiya; E Jimi; S Kokabu; T Katagiri
Journal:  Sci Rep       Date:  2014-12-23       Impact factor: 4.379

Review 5.  Discovery of Heterotopic Bone-Inducing Activity in Hard Tissues and the TGF-β Superfamily.

Authors:  Takenobu Katagiri; Sho Tsukamoto; Yutaka Nakachi; Mai Kuratani
Journal:  Int J Mol Sci       Date:  2018-11-13       Impact factor: 5.923

6.  Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations.

Authors:  Pawel Buczkowicz; Christine Hoeman; Patricia Rakopoulos; Sanja Pajovic; Louis Letourneau; Misko Dzamba; Andrew Morrison; Peter Lewis; Eric Bouffet; Ute Bartels; Jennifer Zuccaro; Sameer Agnihotri; Scott Ryall; Mark Barszczyk; Yevgen Chornenkyy; Mathieu Bourgey; Guillaume Bourque; Alexandre Montpetit; Francisco Cordero; Pedro Castelo-Branco; Joshua Mangerel; Uri Tabori; King Ching Ho; Annie Huang; Kathryn R Taylor; Alan Mackay; Anne E Bendel; Javad Nazarian; Jason R Fangusaro; Matthias A Karajannis; David Zagzag; Nicholas K Foreman; Andrew Donson; Julia V Hegert; Amy Smith; Jennifer Chan; Lucy Lafay-Cousin; Sandra Dunn; Juliette Hukin; Chris Dunham; Katrin Scheinemann; Jean Michaud; Shayna Zelcer; David Ramsay; Jason Cain; Cameron Brennan; Mark M Souweidane; Chris Jones; C David Allis; Michael Brudno; Oren Becher; Cynthia Hawkins
Journal:  Nat Genet       Date:  2014-04-06       Impact factor: 38.330

7.  Bioinformatics analysis of the molecular mechanism of diffuse intrinsic pontine glioma.

Authors:  Lei Deng; Pengju Xiong; Yunhui Luo; Xiao Bu; Suokai Qian; Wuzhao Zhong
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

Review 8.  Recent Topics in Fibrodysplasia Ossificans Progressiva.

Authors:  Takenobu Katagiri; Sho Tsukamoto; Yutaka Nakachi; Mai Kuratani
Journal:  Endocrinol Metab (Seoul)       Date:  2018-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.